| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
2e-12 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-09 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-09 |
| mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
3e-08 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
5e-08 |
| mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
1e-07 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.3 |
4e-07 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |